Financials
- Market Capitalization 384.05 M
- Employee 149
- Founded 2018
- CEO N/A
- Website www.kyvernatx.com
- Headquarter Delaware, United States
- FIGI BBG00RCYMHR1
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2.58
市销率
-6 934.07
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3024 | GALT Galectin Therapeutics Inc. - Common Stock | 3.87 USD | -1.78% | +3.20% | -2.03% | -24.56% | 390.29 M USD | ||
| 3028 | IRD Opus Genetics, Inc. - Common Stock | 4.64 USD | -0.22% | +4.27% | -22.92% | +24.73% | 386.03 M USD | ||
| 3034 | ZURA Zura Bio Limited - Class A Ordinary shares | 4.00 USD | 0.00% | +0.76% | -23.22% | +6.10% | 383.32 M USD | ||
| 3052 | CCCC C4 Therapeutics, Inc. - Common Stock | 3.06 USD | -3.16% | +1.32% | -11.56% | +45.71% | 376.46 M USD |